Bristol-Myers Squibb Company

Organization

New York, NY, US

Ticker Symbols

NYSE:BMY

PHARMACEUTICAL PREPARATIONS
Business Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
State Location
NY
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...
- Patent number 12,247,058
- Issue date Mar 11, 2025
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,241,065
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Amide-substituted heterocyclic compounds for the treatment of condi...
- Patent number 12,240,840
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Steven H. Spergel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of controlling the pink color generated during antibody manu...
- Patent number 12,241,107
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Cheng Du
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of decreasing the galactose content of a recombinant glycop...
- Patent number 12,234,483
- Issue date Feb 25, 2025
- Bristol-Myers Squibb Company
- Jun Tian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Piston valving for serially connectable drug modules of a combinato...
- Patent number 12,233,028
- Issue date Feb 25, 2025
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 12,227,496
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF-21 formulations
- Patent number 12,226,451
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Thomas Palm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
- Patent number 12,227,575
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Sean E. Doyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a tumor using an anti-PD-1 antibody
- Patent number 12,227,576
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Robin Edwards
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine profiling analysis
- Patent number 12,222,356
- Issue date Feb 11, 2025
- Bristol-Myers Squibb Company
- Benedetto Farsaci
- G01 - MEASURING TESTING
Information Patent Grant
Cyclopentyl acids as LPA antagonists
- Patent number 12,209,072
- Issue date Jan 28, 2025
- Bristol-Myers Squibb Company
- Peter Tai Wah Cheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...
- Patent number 12,202,872
- Issue date Jan 21, 2025
- Bristol-Myers Squibb Company
- Mary Struthers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
- Patent number 12,195,444
- Issue date Jan 14, 2025
- Bristol-Myers Squibb Company
- Yan Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 12,194,110
- Issue date Jan 14, 2025
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to VISTA at acidic pH
- Patent number 12,195,535
- Issue date Jan 14, 2025
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzimidazolone compounds
- Patent number 12,187,723
- Issue date Jan 7, 2025
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GSPT1 compounds and methods of use of the novel compounds
- Patent number 12,187,699
- Issue date Jan 7, 2025
- Bristol-Myers Squibb Company
- Joshua Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,180,478
- Issue date Dec 31, 2024
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combinatorial drug delivery device
- Patent number 12,178,781
- Issue date Dec 31, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1H-indazole carboxamides as receptor-interacting protein kinase 1 i...
- Patent number 12,172,975
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted indole and indazole compounds
- Patent number 12,172,995
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- John L. Gilmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,173,069
- Issue date Dec 24, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of measuring hydrophobicity of chromatographic resins
- Patent number 12,174,161
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- Chao Huang
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Apelin receptor agonists and methods of use
- Patent number 12,168,655
- Issue date Dec 17, 2024
- Bristol-Myers Squibb Company
- Wei Meng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of protein tyrosine phosphatase, compositions, and metho...
- Patent number 12,162,848
- Issue date Dec 10, 2024
- Bristol-Myers Squibb Company
- Haibo Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of alkaline washes during chromatography to remove impurities
- Patent number 12,157,073
- Issue date Dec 3, 2024
- Bristol-Myers Squibb Company
- Jue Wang
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Aminotriazolopyridines as kinase inhibitors
- Patent number 12,157,733
- Issue date Dec 3, 2024
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of renal cell carcinoma
- Patent number 12,152,075
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Jason Samuel Simon
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Framework for document layout and information extraction
- Patent number 12,154,362
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Mark Salacinski
- G06 - COMPUTING CALCULATING COUNTING

Patents Applicationslast 30 patents

Information Patent Application
GSPT1 COMPOUNDS AND METHODS OF USE OF THE NOVEL COMPOUNDS
- Publication number 20250092012
- Publication date Mar 20, 2025
- Bristol-Myers Squibb Company
- Joshua Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN RECOVERY
- Publication number 20250092090
- Publication date Mar 20, 2025
- Bristol-Myers Squibb Company
- Abhiram Arunkumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS
- Publication number 20250084056
- Publication date Mar 13, 2025
- Bristol-Myers Squibb Company
- DANIEL FERRANTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASSAY TO DETERMINE IN VIVO RECEPTOR OCCUPANCY
- Publication number 20250085279
- Publication date Mar 13, 2025
- Bristol-Myers Squibb Company
- Naiyu Zheng
- G01 - MEASURING TESTING
Information Patent Application
AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS
- Publication number 20250074909
- Publication date Mar 6, 2025
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RE...
- Publication number 20250066344
- Publication date Feb 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- Sreekantha Ratna Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20250066322
- Publication date Feb 27, 2025
- Bristol-Myers Squibb Company
- MICHAEL EDWARD MERTZMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING TUMORS
- Publication number 20250057948
- Publication date Feb 20, 2025
- Bristol-Myers Squibb Company
- Masano Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR
- Publication number 20250057995
- Publication date Feb 20, 2025
- Bristol-Myers Squibb Company
- Peter Tai Wah Cheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS
- Publication number 20250057815
- Publication date Feb 20, 2025
- Bristol-Myers Squibb Company
- Peter Tai Wah Cheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING TUMOR
- Publication number 20250059610
- Publication date Feb 20, 2025
- Bristol-Myers Squibb Company
- Prabhu Seshaiyer BHAGAVATHEESWARAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS
- Publication number 20250049765
- Publication date Feb 13, 2025
- Bristol-Myers Squibb Company
- Andrew K. Dilger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMS AND METHODS OF SELECTING COMPOUNDS THAT INDUCE CONFORMATION...
- Publication number 20250052749
- Publication date Feb 13, 2025
- Bristol-Myers Squibb Company
- Mary E. Matyskiela
- G01 - MEASURING TESTING
Information Patent Application
LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
- Publication number 20250051448
- Publication date Feb 13, 2025
- Bristol-Myers Squibb Company
- Shivani SRIVASTAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF LAG-3 POSITIVE TUMORS
- Publication number 20250043006
- Publication date Feb 6, 2025
- Bristol-Myers Squibb Company
- James NOVOTNY
- G01 - MEASURING TESTING
Information Patent Application
DETERGENT FOR VIRAL INACTIVATION
- Publication number 20250040546
- Publication date Feb 6, 2025
- Bristol-Myers Squibb Company
- Hasin Maksura FEROZ
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
FRAMEWORK FOR DOCUMENT LAYOUT AND INFORMATION EXTRACTION
- Publication number 20250037494
- Publication date Jan 30, 2025
- Bristol-Myers Squibb Company
- Mark SALACINSKI
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
METHODS OF TREATING COLORECTAL CANCER
- Publication number 20250026831
- Publication date Jan 23, 2025
- Bristol-Myers Squibb Company
- Michael AXELSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A PAR4 INHIBITOR
- Publication number 20250026767
- Publication date Jan 23, 2025
- Bristol-Myers Squibb Company
- Roxana F. Schlam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDI...
- Publication number 20250017941
- Publication date Jan 16, 2025
- Celgene Corporation
- Tonia J. Buchholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RXFP1 AGONISTS
- Publication number 20250011288
- Publication date Jan 9, 2025
- Bristol-Myers Squibb Company
- Adam James Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBO...
- Publication number 20250011466
- Publication date Jan 9, 2025
- Bristol-Myers Squibb Company
- David FELTQUATE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTI...
- Publication number 20250002497
- Publication date Jan 2, 2025
- Bristol-Myers Squibb Company
- Jacques Banville
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20240425505
- Publication date Dec 26, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
- Publication number 20240417471
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- John P. COGSWELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER
- Publication number 20240417473
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Shivani SRIVASTAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES THEREOF
- Publication number 20240417478
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Aaron Paul Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY D...
- Publication number 20240415736
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RXFP1 AGONISTS
- Publication number 20240417369
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Donald J. P. Pinto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER
- Publication number 20240417465
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Laurence David TOMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99075942 - SYSOLVIZ
- Serial number 99075942
- Filing date Mar 10, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99076152 - VYTMIIVO
- Serial number 99076152
- Filing date Mar 10, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99075935 - BYMCLIXIO
- Serial number 99075935
- Filing date Mar 10, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99076365 - LIBHAYLZ
- Serial number 99076365
- Filing date Mar 10, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068223 - DARUZTIO
- Serial number 99068223
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068196 - BIMCLIXIO
- Serial number 99068196
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068228 - DAYFAXLY
- Serial number 99068228
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068245 - QUELGIVO
- Serial number 99068245
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068250 - RYCHOZII
- Serial number 99068250
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068225 - DAYFAXLII
- Serial number 99068225
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068230 - ELBAGAV
- Serial number 99068230
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068231 - ELTAGEMS
- Serial number 99068231
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068234 - FIIMERJUN
- Serial number 99068234
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068237 - FLORAHELO
- Serial number 99068237
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068240 - GOBRYFLO
- Serial number 99068240
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068219 - CLYXPARGO
- Serial number 99068219
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068221 - CYMILVU
- Serial number 99068221
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99068243 - MIQUELXI
- Serial number 99068243
- Filing date Mar 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99047756 - ADHALYF
- Serial number 99047756
- Filing date Feb 19, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042181 - ADWINDSI
- Serial number 99042181
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042193 - ADWISPO
- Serial number 99042193
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042217 - WINZYOND
- Serial number 99042217
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042239 - FAYJENSI
- Serial number 99042239
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042197 - APNUXO
- Serial number 99042197
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042199 - EROWYND
- Serial number 99042199
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042205 - LEROWYND
- Serial number 99042205
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042220 - WYNWISPO
- Serial number 99042220
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042228 - YORJELPA
- Serial number 99042228
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042213 - SUNBRYLI
- Serial number 99042213
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042222 - YORFILGO
- Serial number 99042222
- Filing date Feb 14, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations

Bristol-Myers Squibb Company

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Amide-substituted heterocyclic compounds for the treatment of condi...

Method of controlling the pink color generated during antibody manu...

Methods of decreasing the galactose content of a recombinant glycop...

Piston valving for serially connectable drug modules of a combinato...

Substituted bicyclic compounds as farnesoid X receptor modulators

FGF-21 formulations

Combination of TIM-4 antagonist and PD-1 antagonist and methods of use

Methods of treating a tumor using an anti-PD-1 antibody

Cytokine profiling analysis

Cyclopentyl acids as LPA antagonists

Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...

Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists

PD-L1 binding polypeptides for imaging

Antibodies binding to VISTA at acidic pH

Substituted benzimidazolone compounds

GSPT1 compounds and methods of use of the novel compounds

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Combinatorial drug delivery device

1H-indazole carboxamides as receptor-interacting protein kinase 1 i...

Substituted indole and indazole compounds

Antibodies binding to vista at acidic pH

Methods of measuring hydrophobicity of chromatographic resins

Apelin receptor agonists and methods of use

Inhibitors of protein tyrosine phosphatase, compositions, and metho...

Use of alkaline washes during chromatography to remove impurities

Aminotriazolopyridines as kinase inhibitors

Treatment of renal cell carcinoma

Framework for document layout and information extraction

Patents Applicationslast 30 patents

GSPT1 COMPOUNDS AND METHODS OF USE OF THE NOVEL COMPOUNDS

PROTEIN RECOVERY

SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS

ASSAY TO DETERMINE IN VIVO RECEPTOR OCCUPANCY

AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS

BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RE...

SUBSTITUTED HETEROCYCLIC COMPOUNDS

METHODS OF TREATING TUMORS

RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR

CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

METHODS OF TREATING TUMOR

BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS

SYSTEMS AND METHODS OF SELECTING COMPOUNDS THAT INDUCE CONFORMATION...

LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER

TREATMENT OF LAG-3 POSITIVE TUMORS

DETERGENT FOR VIRAL INACTIVATION

FRAMEWORK FOR DOCUMENT LAYOUT AND INFORMATION EXTRACTION

METHODS OF TREATING COLORECTAL CANCER

CRYSTALLINE FORMS OF A PAR4 INHIBITOR

METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDI...

RXFP1 AGONISTS

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBO...

IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTI...

TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER

ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES THEREOF

SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY D...

RXFP1 AGONISTS

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

Trademarklast 30 trademarks

99075942 - SYSOLVIZ

99076152 - VYTMIIVO

99075935 - BYMCLIXIO

99076365 - LIBHAYLZ

99068223 - DARUZTIO

99068196 - BIMCLIXIO

99068228 - DAYFAXLY

99068245 - QUELGIVO

99068250 - RYCHOZII

99068225 - DAYFAXLII